California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on September 1, 2026

Belite Bio to Participate in Four Upcoming Investor Conferences
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
SEPTEMBER 21, 2026 EQPT INVESTOR DEADLINE: EquipmentShare.com, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - RGRD Law
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
BridgeBio to Participate in September Investor Conferences
Vera Therapeutics to Participate at Upcoming Investor Conferences
Ardelyx to Participate in Upcoming Investor Conferences
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
Kura Oncology to Participate in Three Investor Conferences in September
Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer
AZBio offers ASU tuition scholarships to Member employees and dependents
GetInsured and Change and Innovation Agency Unite Under the Vimo® Name
Efficient LED Driver Driving Up to 4 RGB Dots While Extending the Device Battery Life
Cerebras and Compute Nordic Finland Announce New 165 MW AI Data Centre in Mikkeli, Finland
NexLife Expands Flat-Rate Compounded GLP-1 Program With Microdose and Sublingual Protocols

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.